Clinical Trials · NCT00627406
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Regionshospitalet Viborg, Skive
- Enrollment
- 384
- Start date
- Jan 2009
- Locations
- 1 site, Denmark
- Primary endpoint
- Frequency of Moderate to Severe OHSS.